The anti-infective agents market is expected to grow from US$ 1,35,961.03 million in 2022 to US$ 1,64,196.61 million by 2028; it is estimated to grow at a CAGR of 3.19% from 2022 to 2028.
Anti-infectives are medications that help in preventing and treating infections, such as anti-bacterial, anti-viral, anti-fungal, and antiparasitic medications. Anti-infective therapies help in the treatment of minor infections and many serious infectious diseases such as tuberculosis and pneumonia. These therapies have revolutionized healthcare as they enrich and extend the life of patients suffering from all types of infectious diseases.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Anti-Infective Agents Market: Strategic Insights
Market Size Value in US$ 1,35,961.03 Million in 2022 Market Size Value by US$ 1,64,196.61 Million by 2028 Growth rate CAGR of 3.19% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Anti-Infective Agents Market: Strategic Insights
| Market Size Value in | US$ 1,35,961.03 Million in 2022 |
| Market Size Value by | US$ 1,64,196.61 Million by 2028 |
| Growth rate | CAGR of 3.19% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The anti-infective agents market is segmented into type, range, route of administration, indication, distribution channel, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends and market dynamics and the competitive analysis of the globally leading market players.
Lucrative Regions for Anti-Infective Agents Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Government Support for Research Activities & Clinical Trials and Rising Prevalence of Targeted Diseases Drive Anti-Infective Agents Market
The clinical trials industry has seen exceptional growth in the last 10 years. The US Food and Drug Administration (FDA) revealed in August 2019 that it had awarded 12 new clinical trial research grants that are over US$ 15 million for the next 4 years to improve the development of medical products for patients with rare diseases. The grants were conferred to principal investigators from industry and academics across the US. The FDA awarded grants through the Orphan Products Clinical Trials Grants Program, which congress funds to promote the clinical development of medical foods, biologics, drugs, and medical devices to treat rare diseases. Grants are intended to considerably contribute to the marketing approval of products to treat rare diseases and provide essential data for developing such products. For clinical trials of possibly life-changing treatments for patients with rare diseases, the FDA has been offering much-needed financial support for over 35 years. In addition, the Orphan Products Clinical Trials Grants Program's contributions have supported research that will lead to the marketing approval of treatments for rare diseases in the coming years.
COVID-19 vaccines are developing significantly because more participants are focusing on clinical trials and collaborating to register rapid growth and sufficient production capacity. In addition, the UK government has committed to providing US$ 99.9 million (£84 million) in funding and manufacturing support to researchers to work on the COVID-19 vaccine program.
A few examples of developments that have promoted the growth of the anti-infective agents market are listed below:
- In Oct 2022, Merck expanded its vaccine manufacturing facility in Elkton, VA.
- In Jun 2022, Merck's VAXNEUVANCE drug for Prevention of Invasive Pneumococcal Disease in Infants and Children was approved by US FDA.
- In May 2022, group sales increased by 11% (10% in CHF) to US$ 17.12 billion in the first quarter of the year. This will encourage the company to make better investments and expand.
- In Feb 2022, Roche announced the expansion of the COVID-19 PCR portfolio to the cobas 5800 System, a recently launched molecular laboratory instrument, in countries accepting the CE mark. These include cobas SARS-CoV-2 Qualitative and cobas SARS-CoV-2 & Influenza A/B tests.
- In May 2022, the FDA lifted the clinical hold placed on the Gilead Sciences Investigational New Drug Application (IND) to evaluate injectable lenacapavir for HIV treatment and HIV pre-exposure prophylaxis (PrEP).
- In Apr 2022, the FDA approved a supplemental new drug application of Gilead Sciences for Veklury (remdesivir) for the treatment of pediatric patients under 12 years with COVID-19.
- In Apr 2022, Sandoz, a Novartis Division, announced the extension of its collaboration agreement with Ares Genetics (Ares), aimed at driving cutting-edge digital solutions in the global fight against antimicrobial resistance (AMR).
- In Apr 2022, Novartis announced the introduction of a new organizational structure and operating model designed to support the company’s innovation, growth, and productivity ambitions as a focused medicines company in the coming decade.
Product Insights
Based on type, the anti-infective agents market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment is expected to hold the largest share of the market in 2022. However, the anti-fungal segment is anticipated to register the highest CAGR during the forecast period. An anti-fungal agent is a drug that selectively eliminates fungal pathogens from a host with low toxicity to the host. Anti-fungal medications are available in various forms, including antimetabolite anti-fungal medicines, allylamine and morpholine anti-fungal medicines, polyene anti-fungal medicines, and azole anti-fungal medicines. Systemic and superficial infections, such as skin, eyes, mouth, and vagina infections, can all be caused by fungi. Athlete's foot, ringworm, and fungal meningitis are a few of the disorders that are typically treated using anti-fungal agents with fungicidal activity. Further, increasing numbers of patients with infectious disorders and hospital-acquired or nosocomial infections are anticipated to fuel the market growth. According to the Centers for Diseases Control and Prevention, ~46,000 new cases of invasive candidiasis, a prevalent bloodstream infection in the US, arise each year. Moreover, as per an article published in the National Centre for Biotechnology (NCBI) in 2019, it is estimated that ~1 million cases of cryptococcosis were recorded annually, resulting in 625,000 deaths globally. Thus, the rise in cases of infectious diseases is driving the anti-infective agents market growth.
Anti-Infective Agents Market, by type – 2022 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Range Insights
Based on range, the anti-infective agents market is bifurcated into narrow spectrum and broad spectrum. The narrow spectrum segment is expected to hold a larger market share in 2022. However, the broad spectrum segment is anticipated to register a higher CAGR during the forecast period. Narrow spectrum antibiotics are effective against only a limited range of organisms. Furthermore, the advancements in the treatment are likely to develop more advanced drugs in the coming years. When the causative agent is recognized, narrow spectrum antibiotics are utilized to treat the specific infection since they do not destroy as many normal microorganisms as broad spectrum antibiotics. Therefore, it is less likely to result in superinfection. This reduces bacterial resistance since they exclusively affect certain types of bacteria, such as Azithromycin (a macrolide antibiotic belonging to the azalide subclass) and Clarithromycin. Several global players have well-established R&D with an increased focus on the development of narrow spectrum drugs to avoid the occurrence of multidrug-resistant organisms.
Anti-Infective Agents – Market Segmentation
The anti-infective agents market is segmented into type, range, route of administration, indication, distribution channel, and geography. Based on type, the market is segmented into anti-viral, anti-bacterial, anti-fungal, and others. Based on range, the anti-infective agents market is bifurcated into narrow spectrum and broad spectrum. Based on route of administration, the anti-infective agents market is segmented into IV, oral, topical, and others. Based on indication, the anti-infective agents market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. Based on distribution channel, the anti-infective agents market is categorized into hospital pharmacies, retail pharmacies, specialty pharmacies, e-commerce, and others. By geography, the anti-infective agents market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Company Profiles
Abbott; Allergan Plc.; Astellas Pharma Inc.; Merck & Co., Inc.; Bayer AG; Bristol-Myers Squibb Company; Boehringer Ingelheim International GmbH; F. HOFFMANN-LA ROCHE Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; and Novartis AG are the leading companies operating in the global anti-infective agents market.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Range, Route of Administration, Indication, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Anti-infectives are medications that help in preventing and treating infections, these include antibacterial, antivirals, antifungals and antiparasitic medications. Anti-infective therapies help in treating minor infections as well as many serious infectious diseases tuberculosis or pneumonia. These therapies have revolutionized healthcare as they enrich and extend life of patents suffering from all types of infectious diseases
Factors such as the rising prevalence of targeted diseases and rising government support for research activities and clinical trials.
Emergence of anti-infective drugs resistance and side effects associated with anti-infective drugs is expected to restrict the market growth during the forecast period
The anti-infective agents market majorly consists of the players such as Abbott Laboratories, Inc., Allergan Plc., Astellas Pharma Inc., Merck and Co., Inc., Bayer AG, Bristol-Myers Squibb Co., Boehringer Ingelheim, F. Hoffman-La Roche Ltd., Gilead Sciences, Glaxosmithkline Plc, and Novartis AG.
The global anti-infective agents market based on type, is segmented into anti-viral, anti-bacterial, anti-fungal, and anti-parasitic drug. In 2022, anti-viral segment held largest market share and the segment is estimated to grow at the fastest CAGR during the forecast period.
The global anti-infective agents market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2022, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR during the forecast period
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Anti-Infective Agents Market – By Type
1.3.2 Global Anti-Infective Agents Market – By Range
1.3.3 Global Anti-Infective Agents Market – By Route of Administration
1.3.4 Global Anti-Infective Agents Market – By Indication
1.3.5 Global Anti-Infective Agents Market – By Distribution Channel
1.3.6 Global Anti-Infective Agents Market – By Geography
2. Anti-Infective Agents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Anti-infective agents Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Global Anti-Infectives Agents Market – Key Market Dynamics
5.1 Key Drivers
5.1.1 Rising Prevalence of Targeted Diseases
5.1.2 Rising Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects
5.3 Market Opportunities
5.3.1 Development of New Anti-infective Agents
5.4 Future Trends
5.4.1 Rising Investments in R&D Activities in Pharmaceutical Sector
5.5 Impact Analysis
6. Anti-Infectives Agents Market – Global Analysis
6.1 Global Anti-Infectives Agents Market Revenue Forecast and Analysis
6.1.1 Overview
6.1.2 Global Anti-infectives agents Market, By Geography - Forecast and Analysis
6.1.3 Global Anti-infectives agents Market – Market Potential Analysis, By Region
6.2 Company Analysis
6.2.1 Market Positioning of Key Players
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance of Key Players
6.2.5 Gilead Sciences, Inc.
7. Anti-Infectives Agents Market Analysis and Forecast to 2028 – Type
7.1 Overview
7.2 Global Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
7.3 Anti-Viral
7.3.1 Overview
7.3.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
7.4 Anti-Bacterial
7.4.1 Overview
7.4.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
7.5 Anti-Fungal
7.5.1 Overview
7.5.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. Anti-Infectives Agents Market Analysis and Forecast to 2028 – Range
8.1 Overview
8.2 Global Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
8.3 Narrow Spectrum
8.3.1 Overview
8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
8.4 Broad Spectrum
8.4.1 Overview
8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)
9. Anti-Infectives Agents Market Analysis and Forecast to 2028 – Route of Administration
9.1 Overview
9.2 Global Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
9.3 IV
9.3.1 Overview
9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
9.4.1 Overview
9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)
9.5 Topical
9.5.1 Overview
9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. Anti-Infectives Agents Market Analysis and Forecast to 2028 – Indication
10.1 Overview
10.2 Global Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
10.3 HIV
10.3.1 Overview
10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Tuberculosis
10.4.1 Overview
10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Respiratory Infection
10.5.1 Overview
10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
10.6 Pneumonia
10.6.1 Overview
10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
11. Anti-Infectives Agents Market Analysis and Forecast to 2028 – Distribution Channel
11.1 Overview
11.2 Global Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
11.3.1 Overview
11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
11.4.1 Overview
11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Specialty Pharmacies
11.5.1 Overview
11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.6 E-Commerce
11.6.1 Overview
11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. Anti-Infectives Agents Market Analysis and Forecasts To 2028 – Geographical Analysis
12.1 North America Anti-infectives Agents Market Revenue and Forecasts To 2028
12.1.1 Overview
12.1.2 North America: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3 North America: Anti-Infective Agents Market, by Type, 2019–2028 (US$ Million)
12.1.4 North America: Anti-Infective Agents Market, by Range, 2019–2028 (US$ Million)
12.1.5 North America: Anti-Infective Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.6 North America: Anti-Infective Agents Market, by Indications, 2019–2028 (US$ Million)
12.1.7 North America: Anti-Infective Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.1.8 North America: Anti-Infective Agents Market, by Country, 2022 & 2028 (%)
12.1.8.1 US: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.1 Overview
12.1.8.1.2 US: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.3 US: Anti-Infective Agents Market, by Type, 2019–2028 (US$ Million)
12.1.8.1.4 US: Anti-Infective Agents Market, by Range, 2019–2028 (US$ Million)
12.1.8.1.5 US: Anti-Infective Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.8.1.6 US: Anti-Infective Agents Market, by Indications, 2019–2028 (US$ Million)
12.1.8.1.7 US: Anti-Infective Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.1.8.2 Canada: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.1 Overview
12.1.8.2.2 Canada: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.3 Canada: Anti-Infective Agents Market, by Type, 2019–2028 (US$ Million)
12.1.8.2.4 Canada: Anti-Infective Agents Market, by Range, 2019–2028 (US$ Million)
12.1.8.2.5 Canada: Anti-Infective Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.8.2.6 Canada: Anti-Infective Agents Market, by Indications, 2019–2028 (US$ Million)
12.1.8.2.7 Canada: Anti-Infective Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.1.8.3 Mexico: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.1 Overview
12.1.8.3.2 Mexico: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.3 Mexico: Anti-Infective Agents Market, by Type, 2019–2028 (US$ Million)
12.1.8.3.4 Mexico: Anti-Infective Agents Market, by Range, 2019–2028 (US$ Million)
12.1.8.3.5 Mexico: Anti-Infective Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.8.3.6 Mexico: Anti-Infective Agents Market, by Indications, 2019–2028 (US$ Million)
12.1.8.3.7 Mexico: Anti-Infective Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.2 Europe: Anti-infectives Agents Market
12.2.1 Overview
12.2.2 Europe: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.3 Europe: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.2.4 Europe: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.2.5 Europe: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.6 Europe: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.2.7 Europe: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.2.8 Europe: Anti-Infectives Agents Market, by Country, 2022 & 2028 (%)
12.2.8.1 Germany: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.1 Overview
12.2.8.1.2 Germany: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.3 Germany: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.2.8.1.4 Germany: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.2.8.1.5 Germany: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.1.6 Germany: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.2.8.1.7 Germany: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.2.8.2 UK: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.1 Overview
12.2.8.2.2 UK: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.3 UK: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.2.8.2.4 UK: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.2.8.2.5 UK: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.2.6 UK: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.2.8.2.7 UK: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.2.8.3 France: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.1 Overview
12.2.8.3.2 France: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.3 France: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.2.8.3.4 France: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.2.8.3.5 France: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.3.6 France: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.2.8.3.7 France: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.2.8.4 Italy: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.1 Overview
12.2.8.4.2 Italy: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.3 Italy: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.2.8.4.4 Italy: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.2.8.4.5 Italy: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.4.6 Italy: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.2.8.4.7 Italy: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.2.8.5 Spain: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.1 Overview
12.2.8.5.2 Spain: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.3 Spain: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.2.8.5.4 Spain: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.2.8.5.5 Spain: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.5.6 Spain: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.2.8.5.7 Spain: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.2.8.6 Rest of Europe: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.3 Rest of Europe: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.2.8.6.4 Rest of Europe: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.2.8.6.5 Rest of Europe: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.6.6 Rest of Europe: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.2.8.6.7 Rest of Europe: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.3 Asia Pacific: Anti-infective agents Market
12.3.1 Overview
12.3.2 Asia Pacific: Anti-infective agents Market - Revenue and Forecast to 2028 (US$ Million)
12.3.3 Asia Pacific: Anti-infective agents Market, by Type, 2019–2028 (US$ Million)
12.3.4 Asia Pacific: Anti-infective agents Market, by Range, 2019–2028 (US$ Million)
12.3.5 Asia Pacific: Anti-infective agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.3.6 Asia Pacific: Anti-infective agents Market, by Indication, 2019–2028 (US$ Million)
12.3.7 Asia Pacific: Anti-infective agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.3.8 Asia Pacific: Anti-infective agents Market, by Country, 2022 & 2028 (%)
12.3.8.1 China: Anti-infective agents Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.1 China: Anti-infective agents Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.2 China: Anti-infective agents Market, by Type, 2019–2028 (US$ Million)
12.3.8.1.3 China: Anti-infective agents Market, by Range, 2019–2028 (US$ Million)
12.3.8.1.4 China: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.3.8.1.5 China: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.3.8.1.6 China: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.3.8.2 Japan: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.2.1 Japan: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.2.2 Japan: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.3.8.2.3 Japan: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.3.8.2.4 Japan: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.3.8.2.5 Japan: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.3.8.2.6 Japan: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.3.8.3 India: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.3.1 India: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.3.2 India: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.3.8.3.3 India: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.3.8.3.4 India: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.3.8.3.5 India: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.3.8.3.6 India: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.3.8.4 South Korea: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.4.1 South Korea: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.4.2 South Korea: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.3.8.4.3 South Korea: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.3.8.4.4 South Korea: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.3.8.4.5 South Korea: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.3.8.4.6 South Korea: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.3.8.5 Australia: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.5.1 Australia: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.5.2 Australia: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.3.8.5.3 Australia: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.3.8.5.4 Australia: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.3.8.5.5 Australia: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.3.8.5.6 Australia: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.3.8.6 Rest of Asia Pacific: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.6.1 Rest of Asia Pacific: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.6.2 Rest of Asia Pacific: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.3.8.6.3 Rest of Asia Pacific: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.3.8.6.4 Rest of Asia Pacific: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.3.8.6.5 Rest of Asia Pacific: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.3.8.6.6 Rest of Asia Pacific: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.4 Middle East & Africa: Anti-infective agents Market
12.4.1 Overview
12.4.2 Middle East & Africa: Anti-infective agents Market - Revenue and Forecast to 2028 (US$ Million)
12.4.3 Middle East & Africa: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.4.4 Middle East & Africa Anti-infective agents Market, by Range – Revenue and Forecast to 2028 (USD Million)
12.4.5 Middle East & Africa Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.6 Middle East & Africa Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
12.4.7 Middle East & Africa Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
12.4.8 Middle East & Africa: Anti-infective agents Market, by Country, 2022 & 2028 (%)
12.4.8.1 Saudi Arabia: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.1 Saudi Arabia: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.2 Saudi Arabia: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.4.8.1.3 Saudi Arabia Anti-infective agents Market, by Range – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.4 Saudi Arabia Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.5 Saudi Arabia Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.6 Saudi Arabia Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
12.4.8.2 UAE: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.1 UAE: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.2 UAE: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.4.8.2.3 UAE Anti-infective agents Market, by Range – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.4 UAE Anti-infective agents Market, by Route of Application – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.5 UAE Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.6 UAE Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
12.4.8.3 South Africa: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.1 South Africa: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.2 South Africa: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.4.8.3.3 South Africa Anti-infective agents Market, by Range – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.4 South Africa Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.5 South Africa Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.6 South Africa Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
12.4.8.4 Rest of Middle East & Africa: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.4.1 Rest of Middle East & Africa: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.4.2 Rest of Middle East & Africa: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.4.8.4.3 Rest of Middle East & Africa: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.4.8.4.4 Rest of Middle East & Africa: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.4.8.4.5 Rest of Middle East & Africa: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.4.8.4.6 Rest of Middle East & Africa: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.5 South and Central America Anti-Infective Agents Market
12.5.1 Overview
12.5.2 South and Central America Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.5.3 South and Central America: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.5.4 South and Central America: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.5.5 South and Central America: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.5.6 South and Central America: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.5.7 South and Central America: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.5.8 South and Central America Anti-Infective Agents Market Revenue and Forecast to 2028, by Country (%)
12.5.8.1 Brazil: Anti-Infective Agents Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.1.1 Overview
12.5.8.1.2 Brazil Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.5.8.1.3 Brazil: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.5.8.1.4 Brazil: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.5.8.1.5 Brazil: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.5.8.1.6 Brazil: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.5.8.1.7 Brazil: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.5.8.2 Argentina: Anti-Infective Agents Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.2.1 Overview
12.5.8.2.2 Argentina Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.5.8.2.3 Argentina: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.5.8.2.4 Argentina: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.5.8.2.5 Argentina: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.5.8.2.6 Argentina: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.5.8.2.7 Argentina: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.5.8.3 Rest of the South and Central America: Anti-Infective Agents Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.3.1 Overview
12.5.8.3.2 Rest of the South and Central America Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.5.8.3.3 Rest of the South and Central America: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.5.8.3.4 Rest of the South and Central America: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.5.8.3.5 Rest of the South and Central America: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.5.8.3.6 Rest of the South and Central America: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.5.8.3.7 Rest of the South and Central America: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
13. Impact of COVID-19 Pandemic on Global Anti-Infectives Agents Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13.5 South and Central America: Impact Assessment of COVID-19 Pandemic
14. Anti-infectives Agents Market–Industry Landscape
14.1 Overview
14.2 Growth Strategies In The Anti-infective agents Market, 2018-2022
14.3 Organic Developments
14.3.1 Overview
14.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022
14.4 Inorganic Developments
14.4.1 Overview
14.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022
15. Anti-Infectives Agents Market- Company Profiles
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Allergan Plc.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Astellas Pharma Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Merck & Co., Inc.
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Bayer AG
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Bristol-Myers Squibb Company
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Boehringer Ingelheim International GmbH
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 F. HOFFMANN-LA ROCHE LTD.
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Gilead Sciences, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 GlaxoSmithKline plc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Novartis AG
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Anti-Infective Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Anti-Infective Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Anti-Infective Agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Anti-Infective Agents Market, by Indications – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Anti-Infective Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Anti-Infective Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Anti-Infective Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Anti-Infective Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Anti-Infective Agents Market, by Indications – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Anti-Infective Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Anti-Infective Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Anti-Infective Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Anti-Infective Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Anti-Infective Agents Market, by Indications – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Anti-Infective Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Anti-Infective Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Anti-Infective Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Anti-Infective Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Anti-Infective Agents Market, by Indications – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Anti-Infective Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe: Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 36. France Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 37. France: Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 38. France Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 39. France Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 40. France Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 41. Italy Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy: Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 46. Spain Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain: Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 51. Rest of Europe Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Europe: Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Europe Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Europe Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Europe Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 56. Asia Pacific Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 57. Asia Pacific Anti-infective agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 58. Asia Pacific Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 59. Asia Pacific Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 60. Asia Pacific Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 61. China Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 62. China Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (US$ Million)
Table 63. China Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 64. China Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 65. China Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 66. Japan Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 67. Japan Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 68. Japan Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 69. Japan Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 70. Japan Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 71. India Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 72. India Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 73. India Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 74. India Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 75. India Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 76. South Korea Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 77. South Korea Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 78. South Korea Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 79. South Korea Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 80. South Korea Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 81. Australia Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 82. Australia Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 83. Australia Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 84. Australia Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 85. Australia Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia Pacific Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East & Africa Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East & Africa Anti-infective agents Market, by Range – Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East & Africa Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East & Africa Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East & Africa Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 96. Saudi Arabia Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Anti-infective agents Market, by Range – Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 101. UAE Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Anti-infective agents Market, by Range – Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Anti-infective agents Market, by Route of Application – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 106. South Africa Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Anti-infective agents Market, by Range – Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Middle East & Africa Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East & Africa Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East & Africa Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East & Africa Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East & Africa Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 116. South and Central America Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 117. South and Central America Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 118. South and Central America Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 119. South and Central America Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 120. South and Central America Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 121. Brazil Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 122. Brazil Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 123. Brazil Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 124. Brazil Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 125. Brazil Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 126. Argentina Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 127. Argentina Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 128. Argentina Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 129. Argentina Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 130. Argentina Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 131. Rest of the South and Central America Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 132. Rest of the South and Central America Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 133. Rest of the South and Central America Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 134. Rest of the South and Central America Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 135. Rest of the South and Central America Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 136. Recent Inorganic Growth Strategies In The Anti-infective agents Market
Table 137. Glossary of Terms, Anti-infectives Agents Market
LIST OF FIGURES
Figure 1. Anti-Infective Agents Market Segmentation
Figure 2. Anti-Infective Agents Market Segmentation, by Region
Figure 3. Global Anti-infective agents Market Overview
Figure 4. Anti-Viral Segment Held Largest Share of Product Segment in Anti-Infective Agents Market
Figure 5. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Anti-Infective Agents Market, By Geography (USD Million)
Figure 7. Global Anti-Infective Agents Market- Leading Country Markets (USD Million)
Figure 8. North America: PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Asia Pacific: PEST Analysis
Figure 11. Middle East and Africa: PEST Analysis
Figure 12. South and Central America: PEST Analysis
Figure 13. Experts Opinion
Figure 14. Anti-Infectives Agents Market Impact Analysis of Drivers and Restraints
Figure 15. Global Anti-infectives agents Market– Revenue Forecast and Analysis – 2020 - 2028
Figure 16. Global Anti-infectives agents Market – By Geography Forecast and Analysis – 2022 & 2028
Figure 17. Global Anti-infectives agents Market – Market Potential Analysis, By Region
Figure 18. Market Positioning of Key Players in Global Anti-infectives agents Market
Figure 19. Global Anti-Infectives Agents Market – Comparative Company Analysis
Figure 20. Global Anti-infectives agents Market – Growth Strategy Analysis
Figure 21. Global Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
Figure 22. Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Global Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
Figure 27. Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Global Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
Figure 30. IV Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. Oral Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Topical Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. Global Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
Figure 35. HIV Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. Global Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
Figure 41. Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 42. Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 43. Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 44. E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
Figure 45. Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. North America: Anti-Infective Agents Market, by Key Country – Revenue (2022) (US$ Million)
Figure 47. North America Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. North America: Anti-Infective Agents Market, by Country, 2022 & 2028 (%)
Figure 49. US: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Canada: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Mexico: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Europe: Anti-infectives Agents Market, by Key Country – Revenue (2022) (US$ Million)
Figure 53. Europe Anti-Infectives Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 54. Europe: Anti-Infectives Agents Market, by Country, 2022 & 2028 (%)
Figure 55. Germany: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. UK: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. France: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Italy: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Spain: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Rest of Europe: Anti-Infectives Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Asia Pacific: Anti-infective agents Market, by Key Country – Revenue (2022) (US$ Million)
Figure 62. Asia Pacific Anti-infective agents Market Revenue and Forecast to 2028 (USD Million)
Figure 63. China: Anti-infective agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Japan: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. India: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. South Korea: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Australia: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. Rest of Asia Pacific: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. Middle East & Africa: Anti-infective agents Market, by Key Country – Revenue (2022) (US$ Million)
Figure 70. Middle East & Africa Anti-infective agents Market Revenue and Forecast to 2028 (USD Million)
Figure 71. Middle East & Africa: Anti-infective agents Market, by Country, 2022 & 2028 (%)
Figure 72. Saudi Arabia: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 73. UAE: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. South Africa: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 75. Rest of Middle East & Africa: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 76. South and Central America Anti-Infective Agents Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 77. South and Central America Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 78. South and Central America Anti-Infective Agents Market Revenue and Forecast to 2028, by Country (%)
Figure 79. Brazil: Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 80. Argentina: Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 81. Rest of the South and Central America: Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 82. Impact of COVID-19 Pandemic on North America Countries
Figure 83. Impact of COVID-19 Pandemic on European Countries
Figure 84. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 85. Impact of COVID-19 Pandemic in Rest of World Country Markets
Figure 86. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 87. Growth Strategies In The Anti-infective agents Market, 2018-2022
Figure 88. Recent Organic Growth Strategies In The Anti-infective agents Market
The List of Companies - Anti-Infective Agents Market
- Abbott
- Allergan Plc.
- Astellas Pharma Inc.
- Merck & Co., Inc.
- Bayer AG
- Bristol-Myers Squibb Company
- Boehringer Ingelheim International GmbH
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline plc.
- Novartis AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Anti-Infective Agents Market
Jul 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jul 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jul 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)